Alcohol use disorder increases risk of major adverse limb events following lower-extremity revascularization for

Samantha N Machinski1, Mikayla Lowenkamp2, Lindsey Olivere2

  • 1Division of Vascular Surgery, UPMC, Pittsburgh, PA.

Journal of Vascular Surgery
|February 26, 2026
PubMed

Insights

Patients with alcohol use disorder (AUD) face higher risks of major adverse limb events, amputation, and mortality after lower extremity revascularization for chronic limb-threatening ischemia (CLTI). Identifying AUD preoperatively can improve risk assessment.

Area of Science:

  • Vascular Surgery
  • Addiction Medicine
  • Cardiovascular Outcomes Research

Background:

  • Chronic limb-threatening ischemia (CLTI) affects numerous patients, with a significant portion undergoing major amputation.
  • Excessive alcohol consumption is linked to adverse cardiovascular outcomes, yet its impact on CLTI patients with alcohol use disorder (AUD) remains understudied.

Purpose of the Study:

  • To investigate the association between alcohol use disorder (AUD) and major adverse limb events (MALE) in adults undergoing lower extremity revascularization for CLTI.
  • To evaluate the impact of AUD on amputation and mortality rates in this patient population.

Main Methods:

  • Retrospective analysis of electronic health records from a unified healthcare system (2016-2024).
  • Inclusion of adult patients with CLTI undergoing index lower extremity revascularization (endovascular or open).
  • AUD identified using validated ICD-10-CM codes; one-year MALE, major amputation, and mortality assessed using Fine Gray and Cox regression, risk-adjusted for competing mortality.

Main Results:

  • Among 3,744 CLTI patients, 4.9% had AUD and were more likely male and tobacco users.
  • AUD diagnosis was independently associated with increased risk of one-year MALE (sHR=1.29) and significantly higher risk of major amputation (sHR=1.94) and mortality (aHR=1.51).
  • No significant association found between AUD and major revascularization failure (sHR=1.14).

Conclusions:

  • Alcohol use disorder independently increases the risk of MALE, major amputation, and mortality in patients undergoing lower extremity revascularization for CLTI.
  • Preoperative identification of AUD is crucial for refining risk stratification in this vulnerable patient group.
  • Further research into AUD management strategies within vascular surgery is warranted.
Abstract

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
473
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
433
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
494
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
531
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
487
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
320